Does Creatine Cause Hair Loss? What the Research Shows

Current evidence does not establish that creatine causes hair loss. The concern traces to a single small study, and that study did not measure hair loss at all — it measured a hormonal marker that may or may not be relevant to hair thinning in any given individual.

Creatine monohydrate is one of the most studied performance supplements available, with a safety profile examined across decades of research by organizations including the International Society of Sports Nutrition. The hair-loss question, however, keeps circulating because one 2009 trial produced a finding that sounds alarming on the surface. Understanding what that study actually measured — and what it did not — gives you a far more accurate picture of your real risk. For the wider safety picture, read our review of whether creatine is safe long term.

The 2009 DHT Study: What It Found and What It Did Not

The study at the center of this debate — published in Clinical Journal of Sport Medicine in 2009 — recruited 20 male college-aged rugby players and divided them into a creatine group and a placebo group. Researchers measured serum levels of dihydrotestosterone, commonly called DHT, before and after a loading and maintenance protocol. The creatine group showed a statistically significant increase in the DHT-to-testosterone ratio after the loading phase and after the maintenance phase compared to placebo. That is the complete finding. The study did not observe, photograph, measure, or record any instance of hair loss in any participant.

DHT is an androgen derived from testosterone via the enzyme 5-alpha reductase. It binds to receptors in hair follicles and, in individuals with a genetic predisposition to androgenetic alopecia, can accelerate follicle miniaturization over time. The biological pathway from elevated DHT to actual hair loss is real. The problem is that the 2009 study established only that a surrogate marker shifted — not that the shift translated into follicle damage or visible thinning in any participant.

Sample Size and Replication Problems

Twenty participants is a sample size too small to draw population-level conclusions. A single trial with no replication carries limited weight in evidence-based practice, and that limitation applies directly here. As of the most recent systematic reviews of creatine supplementation, no subsequent peer-reviewed study has replicated the DHT elevation finding, and no study has documented creatine-induced hair loss as a measured outcome. The NSCA’s position resources on ergogenic aids and multiple reviews in the Journal of the International Society of Sports Nutrition do not list androgenetic alopecia among established adverse effects of creatine. Absence of replicated evidence is not proof of zero risk, but it does place the hair-loss claim at a low level of scientific confidence.

What DHT Actually Does — and Who Is at Risk

DHT performs legitimate physiological functions. It plays a central role in male sexual development and contributes to muscle tissue regulation. Its association with hair loss is specific to a genetic condition — androgenetic alopecia — in which hair follicles express a heightened sensitivity to androgens. Individuals without this genetic variant can have elevated DHT levels without experiencing meaningful follicle miniaturization. DHT’s effect on hair is not universal; it is conditional on follicle receptor sensitivity inherited through genetics.

Androgenetic alopecia affects roughly 50% of men by age 50 and a meaningful percentage of women, according to data cited by the American Academy of Dermatology. If you carry the genetic predisposition, any factor that meaningfully elevates DHT — including anabolic steroids, certain medications, and possibly the hormonal shifts seen in the 2009 creatine study — represents a legitimate concern worth discussing with a physician. If you do not carry that predisposition, a transient shift in the DHT-to-testosterone ratio is far less likely to produce clinical hair thinning. Your personal and family history of hair loss is the most relevant variable in your individual risk assessment.

Androgenetic Alopecia and Genetic Predisposition

Genetic predisposition to androgenetic alopecia is inherited through multiple genes, not a single marker. A strong family history of early-onset hair loss — particularly on the maternal grandfather’s side, though paternal history matters too — suggests higher follicle androgen sensitivity. If you have that history and you are already monitoring signs of thinning, a conservative approach to any intervention that might influence androgen metabolism is rational. Consulting a dermatologist or endocrinologist before starting creatine gives you a personalized risk picture rather than a population-level guess.

What Long-Term Creatine Research Shows

Long-term safety data on creatine monohydrate is extensive relative to most sports supplements. Research published in the Journal of the International Society of Sports Nutrition — including a comprehensive review by Rawson and colleagues — consistently shows no clinically significant adverse effects on kidney function, liver enzymes, or hormonal panels in healthy individuals using studied doses over periods ranging from weeks to years. The hair-loss question is an outlier concern within a broader safety record that is well-characterized. Creatine’s primary studied benefits — increased phosphocreatine resynthesis, improved high-intensity output, and enhanced recovery between sets — remain among the most replicated findings in exercise science.

How to Use Creatine Responsibly: Dose, Form, and Quality

The 2009 DHT study used a loading phase of 25 grams per day for 7 days, followed by a maintenance dose of 5 grams per day for 14 days. Most subsequent studies examining performance outcomes have used 3-5 grams per day without a loading phase, producing equivalent phosphocreatine saturation over roughly 28 days with no acute spike in intake. Skipping the loading phase does not eliminate the hormonal question, since the study showed DHT elevation during maintenance as well — but it does avoid the high short-term dose that makes some users uncomfortable.

Creatine monohydrate is the form used in the overwhelming majority of clinical research, including the 2009 trial. Proprietary forms — creatine hydrochloride, buffered creatine, and others — carry fewer studies supporting their efficacy and no comparative safety advantage over monohydrate. When selecting a product, third-party certification matters. NSF Certified for Sport and Informed Sport are two credible certification programs that verify a product’s label accuracy and test for banned substances. Neither certification addresses the DHT question directly, but both indicate you are getting the dose and compound the label states, which is the baseline requirement for any supplement decision.

Who Should Avoid Creatine or Talk to a Doctor First

Certain populations should not use creatine without explicit medical clearance. Individuals with pre-existing kidney disease or a single functioning kidney should discuss creatine with a nephrologist before use, since creatine metabolism produces creatinine — a marker used to assess kidney function — and elevated creatinine can complicate clinical monitoring. Pregnant and breastfeeding individuals should avoid creatine due to insufficient safety data in those populations. Anyone currently taking medications that affect renal clearance, blood pressure, or androgen levels should consult their prescribing physician before adding creatine, since interactions with those systems are plausible even if not fully characterized.

If you have a diagnosed hormonal condition — including polycystic ovary syndrome, which involves elevated androgens — a conversation with your endocrinologist is appropriate before starting. The goal is not to create alarm where the evidence does not support it; the goal is to make a decision that accounts for your individual physiology rather than population averages.

Practical Takeaways for Natural Lifters

• The hair-loss link is based on one unreplicated study measuring a hormonal marker, not observed hair loss.
• Your genetic predisposition to androgenetic alopecia is the most important variable in your personal risk assessment.
• Studies used 3-5 grams per day of creatine monohydrate as a maintenance dose; this is the form and range with the broadest research support.
• Skipping the loading phase (25 g/day for 7 days) achieves the same saturation over 28 days and avoids the acute high-dose period used in the 2009 trial.
• Choose products with NSF Certified for Sport or Informed Sport certification to confirm label accuracy and absence of adulterants.
• Talk to your doctor before starting if you have kidney disease, take medications affecting hormones or renal function, are pregnant, or are managing a diagnosed endocrine condition.

The research does not support the claim that creatine causes hair loss. One small study found a transient elevation in the DHT-to-testosterone ratio — a finding that has not been replicated and that did not include any measurement of actual hair thinning. If you carry a strong genetic predisposition to androgenetic alopecia, discuss the question with your doctor and factor it into your decision. For most natural lifters without that predisposition, the evidence does not justify avoiding one of the most well-researched performance supplements in exercise science.

Frequently Asked Questions